Professional Documents
Culture Documents
Huang Honghui
Department of Hematology
Ren Ji Hospital
Case Summary
26 year-old, female patient
persistent nasal bleeding for one day, have an upper respi-
ratory infection 2 weeks previously. No fever, chills, nausea,
vomiting, abdominal pain, or joint pain.
PE: multiple l-mm reddish spots on her lower extremities.
No lymphadenopathy or hepatosplenomegaly.
No excessive bleeding with menses, childbirth, prior
epistaxis, easy bruisability, or bleeding into her joints.
No family history of abnormal bleeding.
Not take any medication.
Objects of Analysis
Learn the clinical approach to bleeding disorders, specificly
sequestration (hypersplenism)
dilutional
Spurious Thrombocytopenia
Automated cell counters reports spurious
thrombocytopenia in approximately 0.l% of
patients.
This is generally a result of platelet dumping after
drawing blood into the anticoagulant ethylene
diamine tetra acetate (EDTA) .
Confirmation
Identifying platelet aggregates on peripheral blood
smear
Using citrate or heparin as an anticoagulant
Impaired platelet production
Infiltration caused by malignancy or
myelofibrosis
Marrow hypoplasia
Chemicals
Drugs
Radiation
Viruses
Decrease platelet survival
immune thrombocytopenia purpua (caused by IgG antibody
against the platelets),
drug-induced thrombocytopenic purpura
secondary immunologic purpura (as in lymphoma,
lupus,infection with human immunodeficiency virus type 1)
posttransfusion purpura.
Disseminated intravascular coagulation
hemolytic uremic syndrome
cavernous hemangioma
acute infections
ITP
Acute ITP
early childhood
antecedent upper respiratory infection
self-limiting, usually resolves spontaneously within 3-6
months.
Chronic ITP
in adults, most likely to occur in women ages 20-40
years
an insidious or subacute present.
persist for months to Years, with uncommon
spontaneous remission.
Several immunologic disorders
may mimic true ITP
drug induced thrombocytopenic purpura
Discontinuation of the medication should lead to
improvement in the platelet count within a time frame
consistent with the drugs metabolism.
Many drugs are blown to cause thrombocytopenic
purpura, such as quinidine and quinine, Sulfonamide,
heparin, and gold compounds.
SLE
Lymphoma
Lymphadenopathy
splenomegaly
HIV-1 infection
Posttransfusion purpura
Nonimmunologic disorders may
mimic true ITP
DIC
TTP
DIC
ETIOLOGY
Secondary to some other process: sepsis, trauma,
metastatic malignancy, obstetric causes
CLINICAL COURSE
can be relatively mild indolent course, or severe llfe-
threatening process;
ongoing coagulation and fibrinolysis;
can cause thrombosis or hemorrhage;
consumption of coagulation factors is seen as prolonged
PT and PTT
DIC
TREATMENT
Treatment aimed at underlying cause.
TREATMENT
Plasmapheresis (removal of the
excess/abnormal vWF), most patients
recover
corticosteroids
ITP
ETIOLOGY
Antiplatelet antibody leading to platelet destruction
CLINICAL COURSE
Children:following a Viral illness with resolution.
Adults:a more indolent course with progression and
rarelys spontaneous resolution.
Isolated thrombocytopenia, normal PT, PTT.
Increased megakaryocytes on bone marrow aspiration.
ITP
TREATMENT
Oral Corticosterolds,
Immunosuppressants
Intravenous Immmoglobulin
Answers
Oral corticosteroids
Comprehension Questions
A 50-year-old man has been treated for rheumatoid
arthritis for many years. He is currently taking
corticosteroids for the disease.On examination, he has
stigmata of rheumatoid arthritis and some fullness on his
left upper abdomen. His platelet count is slightly low at
56,000/mm3. His WBC count is 3,100/mm3 and Hgb
9.Og/dL. Which of the following is the most likely etiology
of the thrombocytopenia?
A.Steroid induced
B.Sequestration
C.Rheumatoid arthritis autoimmune induced
D.Prior gold therapy
Comprehension Questions
A 30-year-old woman with ITP has been taking
maximum corticosteroid doses and still has a
platelet count of 20,000/mm3 and frequent
bleeding episodes. Which of the following should
she receive before her splenectomy?
A.Washed leukocyte transfusion
B.Intravenous interferon therapy
C.pneumococcal vaccine
D.Bone marrow radiotherapy
CLINICAL PEARLS
Bleeding abnormalities can be divided into
primary hemostatic problems (platelet plug at
time of injury)and secondary hemostasis
(creation of a stable fibrin clot).
Disorders of primary hemostasis
(thrombocytopenia or von Willebrand) are
characterized by mucosal bleeding and the
appearance of petechiae or superficial
ecchymoses.
CLINICAL PEARLS
Disorders of secondary hemostasis (coagulation factor
deficiencies such as hemophilia)are usually characterized by
the development of superficial ecchymoses,as well as deep
hematomas and hemarthroses.
ITP is a diagnosis of exclusion.Patients have isolated
thrombocytopenia(i.e.,no red or white blood cell
abnormalities),no apparent secondary causes such as
systemic lupus erythematosus, HIV or medication-induced
thrombocytopenia, and normal to increased numbers of
megakaryocytes in the bone marrow.
CLINICAL PEARLS
Treatment of ITP
Corticosteroids are the initial treatment of ITP.